COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities
- PMID: 32914200
- PMCID: PMC7483054
- DOI: 10.1007/s00431-020-03801-6
COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities
Abstract
Data show that children are less severely affected with SARS-Covid-19 than adults; however, there have been a small proportion of children who have been critically unwell. In this systematic review, we aimed to identify and describe which underlying comorbidities may be associated with severe SARS-CoV-2 disease and death. The study protocol was in keeping with Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. A total of 1726 articles were identified of which 28 studies fulfilled the inclusion criteria. The 28 studies included 5686 participants with confirmed SARS-CoV-2 infection ranging from mild to severe disease. We focused on the 108 patients who suffered from severe/critical illness requiring ventilation, which included 17 deaths. Of the 108 children who were ventilated, the medical history was available for 48 patients. Thirty-six of the 48 patients (75%) had documented comorbidities of which 11/48 (23%) had pre-existing cardiac disease. Of the 17 patients who died, the past medical history was reported in 12 cases. Of those, 8/12 (75%) had comorbidities.Conclusion: Whilst only a small number of children suffer from COVID-19 disease compared to adults, children with comorbidities, particularly pre-existing cardiac conditions, represent a large proportion of those that became critically unwell. What is Known: • Children are less severely affected by SARS-CoV-2 than adults. • There are reports of children becoming critically unwell with SARS-CoV-2 and requiring intensive care. What is New: • The majority of children who required ventilation for SARS-CoV-2 infection had underlying comorbidities. • The commonest category of comorbidity in these patients was underlying cardiac disease.
Keywords: Adolescent; COVID-19; Comorbidities; Critically unwell; Paediatric; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Conflict of interest statement
The authors declare that they have no conflict of interest.
Comment in
-
Comment on "COVID-19 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities".Eur J Pediatr. 2021 Oct;180(10):3251-3252. doi: 10.1007/s00431-021-04036-9. Epub 2021 Mar 25. Eur J Pediatr. 2021. PMID: 33763716 Free PMC article. No abstract available.
Similar articles
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Comment on "COVID-19 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities".Eur J Pediatr. 2021 Oct;180(10):3251-3252. doi: 10.1007/s00431-021-04036-9. Epub 2021 Mar 25. Eur J Pediatr. 2021. PMID: 33763716 Free PMC article. No abstract available.
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
-
Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.EClinicalMedicine. 2022 Feb;44:101287. doi: 10.1016/j.eclinm.2022.101287. Epub 2022 Feb 11. EClinicalMedicine. 2022. PMID: 35169689 Free PMC article.
-
Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.J Pediatr Rehabil Med. 2020;13(3):301-316. doi: 10.3233/PRM-200794. J Pediatr Rehabil Med. 2020. PMID: 33252101 Review.
Cited by
-
Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivity.iScience. 2023 Dec 14;27(1):108728. doi: 10.1016/j.isci.2023.108728. eCollection 2024 Jan 19. iScience. 2023. PMID: 38235336 Free PMC article.
-
Gastrointestinal Manifestations Are Associated with Severe COVID-19 in Children.Healthcare (Basel). 2023 Dec 29;12(1):81. doi: 10.3390/healthcare12010081. Healthcare (Basel). 2023. PMID: 38200987 Free PMC article.
-
Risk factors for severe disease and mortality in children with COVID-19.Heliyon. 2023 Dec 13;10(1):e23629. doi: 10.1016/j.heliyon.2023.e23629. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38192840 Free PMC article.
-
Pediatric COVID-19: clinical and epidemiological data of 1303 cases in a general hospital in Brazil.Rev Paul Pediatr. 2023 Dec 22;42:e2023031. doi: 10.1590/1984-0462/2024/42/2023031. eCollection 2023. Rev Paul Pediatr. 2023. PMID: 38126598 Free PMC article.
-
Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups.Ital J Pediatr. 2023 Oct 8;49(1):135. doi: 10.1186/s13052-023-01485-w. Ital J Pediatr. 2023. PMID: 37807040 Free PMC article.
References
-
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for Covid-19 Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
-
- World Health Organization (WHO). WHO Director-General’s opening remarks at the media briefing on COVID-19: 11 March 2020. Published March 11, 2020. Accessed 30th June 2020
-
- Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ramírez-Vallejo E, Suárez JA, Zambrano LI, Villamil-Gómez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R, Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi: 10.1016/j.tmaid.2020.101623. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous